文献速递血液净化与透析慢性肾脏病

血液透析患者血镁水平与髋部骨折风险的关系

Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis.
PubMed 文献 · J Am Soc Nephrol · 2017-11-30

本研究基于日本全国透析患者数据库,纳入113,683例无髋部骨折史的血液透析患者,随访2年。主要发现血镁水平较低四分位组髋部骨折发生率显著更高,Q1组较Q4组风险增加1.23倍(95%CI 1.06-1.44,P<0.01),血镁对髋部骨折的人群归因分数为13.7%。结论提示轻度高镁血症与较低的髋部骨折风险相关。

要点

  • 血镁较低者髋部骨折风险更高,Q1较Q4风险增加1.23倍。
  • 血镁对髋部骨折的人群归因分数为13.7%,高于血钙、血磷和PTH。
  • 轻度高镁血症可能与血液透析患者较低的髋部骨折风险相关。

核心结论

  • 在日本血液透析患者中,轻度高镁血症与较低的髋部骨折风险相关。

研究设计与样本

  • 基于日本全国透析患者数据库的队列研究,纳入113,683例无髋部骨折史的血液透析患者,随访2年。

主要发现

  • 随访2年内共发生2305例(2%)新发髋部骨折。
  • Q1-Q4组粗发生率分别为2.63%、2.08%、1.76%、1.49%(P<0.001 for trend)。
  • 校正人口学和临床因素后,Q1组较Q4组髋部骨折风险增加1.23倍(95%CI 1.06-1.44;P<0.01)。
  • 逆概率加权分析同样显示较低镁四分位组髋部骨折风险增加。
  • 亚组分析未观察到显著效应修饰,血镁对髋部骨折的人群归因分数为13.7%(95%CI 3.7%-22.7%)。

关键数值与推荐

  • 血清镁四分位范围(mg/dL):Q1 <2.3;Q2 2.4-2.6;Q3 2.7-2.8;Q4 >2.9。

临床怎么用

  • 血镁水平可作为血液透析患者髋部骨折风险评估的参考指标。
  • 血镁对髋部骨折的人群归因分数高于血钙、血磷和PTH,提示其临床相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnesium is an essential mineral for bone metabolism. However, little is known about the relationship between magnesium and the risk of fractures. In this cohort study, we elucidated the association between serum magnesium level and the risk of incident hip fracture among patients undergoing hemodialysis. We identified 113,683 patients undergoing hemodialysis with no history of hip fracture from a nation-wide database of patients undergoing dialysis in Japan. During a 2-year follow-up, a total of 2305 (2%) new hip fractures occurred. The crude incidence rate was significantly higher among patients in the lower quartiles of serum magnesium levels (2.63%, 2.08%, 1.76%, and 1.49% in Q1-Q4, respectively; P<0.001 for trend). The range of serum magnesium levels (in milligrams per deciliter) in each quartile was as follows: Q1, <2.3; Q2, 2.4-2.6; Q3, 2.7-2.8, and Q4, >2.9. After adjustment for demographic and clinical factors, patients in Q1 had a 1.23-fold higher risk for hip fracture than those in Q4 (95% confidence interval, 1.06 to 1.44; P<0.01). Similarly, an inverse probability weighting analysis showed an increased risk of hip fracture among patients in the lower magnesium quartiles. We did not observe significant effect modifications in subgroup analyses. The population-attributable fraction of serum magnesium level for incident hip fractures was 13.7% (95% confidence interval, 3.7% to 22.7%), which was much higher than that of serum calcium, serum phosphate, and parathyroid hormone levels. Thus, mild hypermagnesemia is associated with a lower risk of hip fracture among patients undergoing hemodialysis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sakaguchi Y, Hamano T, Wada A, et al. Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis. J Am Soc Nephrol. 2017. PMID: 29191960. doi:10.1681/ASN.2017080849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。